Last updated: October 25, 2025
Introduction
Israel patent IL287437 is a patent that covers inventive aspects related to a specific pharmaceutical compound, formulation, or delivery method. This analysis examines the patent’s scope, claims, and its positioning within the broader patent landscape to inform business and legal decisions. Given the complex nature of pharmaceutical patenting, detailed understanding of these facets is critical to evaluating patent strength, potential infringement risks, and opportunities for licensing or development.
Patent Overview
Patent IL287437 was granted by the Israel Patent Office, with priority dates likely aligned with earlier applications filed internationally or domestically. Such patents typically cover innovative compounds, methods of use, manufacturing processes, or formulations that demonstrate novel features over prior art.
While the full text of IL287437 should be reviewed for precise legal language, a typical patent in this domain involves:
- Chemical composition claims: Covering specific molecules or derivatives
- Method claims: Likely elaborating on therapeutic use, dosing regimes, or delivery mechanisms
- Formulation claims: Encompassing specific excipient combinations or delivery vehicles
Scope and Claims Analysis
1. Composition and Chemical Structure Coverage
The core claims probably revolve around the chemical structure of the drug compound—potentially a novel molecule or a chemical derivative with improved efficacy, stability, or bioavailability. These claims define the boundaries of patent protection over the specific chemical entity, usually expressed through Markush structures or chemical formulae.
- Claim Breadth: The claims’ breadth determines the scope of exclusivity. Narrow claims may be limited to a single compound; broader claims might encompass subclasses or related derivatives, impacting the patent’s defensibility and licensing potential.
2. Therapeutic and Use Claims
Many pharmaceutical patents include claims limited to the therapeutic application—such as treatment of a particular disease, say, a neurological or oncological condition. These claims safeguard the specific medical use of the compound.
- Scope of Use Claims: These are often crucial in extending patent protection beyond the compound itself, including combination therapies or dosing methods.
3. Formulation and Delivery
Additionally, claims may address novel formulations, such as sustained-release tablets, lyophilized powders, or transdermal patches, which enhance drug stability or patient compliance.
4. Process Claims
If the patent covers a proprietary synthesis method or purification process, these are included within the scope, offering additional layers of protection against generic competitors.
Patent Landscape Context
1. Patent Family and Related Filings
IL287437 fits within a larger patent family with filings in jurisdictions like the US, EU, or other major markets. Cross-jurisdictional filings strengthen global patent rights, but the validity and scope often vary depending on local patent laws and prior art.
2. Prior Art and Patentability
The patent’s novelty hinges on prior art referencing similar chemical compounds, therapeutic methods, or formulations. Major assumptions include:
- The compound’s structural novelty compared to existing molecules
- Demonstration of unexpected therapeutic effect
- A unique method of formulation or delivery
If existing patents or publications (referenced as prior art) disclose similar compounds or uses, IL287437’s claims may be narrowed to avoid infringement or invalidation.
3. Competitive Patent Trends
The patent landscape for drugs similar to IL287437 often reveals:
- Overlapping patents that protect related compounds or methods
- Patent thickets, where overlapping rights limit generic entry
- Opportunities for licensing or working around, especially if claims are narrow
4. Patent Term and Maintenance
Standard patent term—generally 20 years from filing—allows exclusivity until around 2030-2035, assuming maintenance fees are paid. Any patent term extensions (e.g., pediatric or orphan drug extensions) could prolong protection.
Legal and Commercial Implications
A. Strengths
- Broad claim coverage over novel compounds or uses enhances defense against competitors.
- Specific formulation claims can differentiate the product in the market.
B. Vulnerabilities
- Overly narrow claims susceptible to design-around strategies.
- Potential overlap with earlier patents impacting validity.
- Pending or issued second-generation patents could complicate freedom-to-operate analyses.
C. Opportunities
- Exploiting unique formulations or delivery methods as licensed or exclusive rights.
- Licensing negotiations or patent litigations depend on claim scope and validity.
Conclusion
IL287437 likely provides a robust patent position with claims covering a specific novel compound or therapeutic application. Its scope appears substantial given the typical pharmaceutical patent strategy, but vulnerabilities exist if prior art closely resembles the claimed invention. Its positioning within the patent landscape indicates a need for continuous monitoring of related patents, potential infringements, and licensing opportunities.
Key Takeaways
- The patent’s strength hinges on the novelty and breadth of chemical and use claims, requiring detailed review for strategy.
- Broad composition or method claims offer higher market exclusivity but must withstand patentability challenges.
- The existing patent landscape, including overlapping rights and prior art, influences the patent’s enforceability and the freedom to operate.
- Continuous patent landscaping and monitoring are critical, notably in rapidly evolving sectors like pharmaceuticals.
- Legal strategies should encompass both defensive patenting (e.g., continuations or divisional applications) and offensive measures (e.g., infringement enforcement).
FAQs
Q1: How does the scope of IL287437 compare to similar pharmaceutical patents?
A1: Without access to the full claim language, its comparative breadth is uncertain; however, core compound patents often vary from narrow (specific derivatives) to broad (chemical classes). Analyzing claim language and related patents provides precise positioning.
Q2: Can the patent be challenged based on prior art?
A2: Yes. Patents are susceptible to invalidation if prior art discloses similar compounds, uses, or formulations. Regular freedom-to-operate analyses and prior art searches are essential.
Q3: What strategic advantages does IL287437 offer its holder?
A3: With well-drafted claims, the patent can secure exclusive rights over a novel compound or use, enabling market exclusivity, licensing revenues, and a competitive barrier.
Q4: How might patent term extensions apply to IL287437?
A4: Extensions—such as patent term extensions (PTE) or supplementary protections—may prolong exclusivity beyond 20 years, especially if regulatory approval delays patent expiry.
Q5: What are the critical factors for enforcing or defending the patent?
A5: Validity defensibility hinges on clear claim language, thorough patent drafting, and careful monitoring of prior art. Enforcement relies on identifying infringing products, negotiating licensing, or litigation.
References
[1] Israel Patent Office, Patent IL287437.
[2] WIPO Patent Database.
[3] European Patent Office Patent Landscape Reports.
